Resource Type

Journal Article 6

Year

2012 1

2009 1

2008 1

Keywords

apoptosis 2

melanoma 2

Salmonella VNP20009 1

B16F10 1

BCL2 1

BNCT 1

CD437 1

Ca2+/CaMKII signaling pathway 1

GBM 1

angiogenesis 1

celecoxib 1

combination target therapy 1

cycle arrest 1

malignant melanoma 1

melanoma A375 cell 1

metastatic liver cancer 1

mutant GNAQ/11 1

neuropilin and tolloid-like 2 1

palmitoylation 1

open ︾

Search scope:

排序： Display mode:

NETO2 promotes melanoma progression via activation of the Ca/CaMKII signaling pathway

Frontiers of Medicine doi: 10.1007/s11684-022-0935-0

Abstract: Melanoma is the most aggressive cutaneous tumor.However, the functional significance of NETO2 in melanoma progression remains unclear.Herein, we found that NETO2 expression was augmented in melanoma clinical tissues and associated withpoor prognosis in melanoma patients.indicating that targeting NETO2 may effectively improve melanoma treatment.

Keywords： melanoma     neuropilin and tolloid-like 2     Ca2+/CaMKII signaling pathway    

HTML PDF Collect
Share

Celecoxib in combination with retinoid CD437 inhibits melanoma A375 cell

Jianwen REN, Zhenhui PENG, Birong GUO, Min PAN

Frontiers of Medicine 2009, Volume 3, Issue 1,   Pages 108-112 doi: 10.1007/s11684-009-0015-8

Abstract: and the combination of the two on cell proliferation, apoptosis, and cycle arrest of human malignant melanoma(MTT assay) was applied to determine the anti-proliferative effects of the drugs on human malignant melanomaBoth celecoxib and CD437 could inhibit the growth of human malignant melanoma A375 cells in a dose-dependentCelecoxib could inhibit the growth of human malignant melanoma A375 cells by inducing apoptosis and GCD437 could inhibit the growth of human malignant melanoma A375 cells by inducing apoptosis and G /G

Keywords： celecoxib     CD437     melanoma A375 cell     apoptosis     cycle arrest    

HTML PDF Collect
Share

Inhibitory activity of Bifidobacterium adolescent combined with cisplatin on melanoma in mice and its

HUANG Hongying, LIU Guangchao, QI Yijun, DU Yaowu, CHEN Jugao, MA Yuanfang

Frontiers of Medicine 2008, Volume 2, Issue 2,   Pages 186-190 doi: 10.1007/s11684-008-0035-9

Abstract: explore inhibitory activity of Bifidobacterium adolescent combined with cisplatin on the growth of melanomaC57 mice were inoculated with B16 cancer cells to construct mouse model of melanoma and treated withRatios of inhibitory activity on the growth of melanoma (B16) were calculated.When bifidobacterium of 10 cfu/L was injected, the ratio of inhibitory activity on the growth of melanomaTreatment with bifidobacterium combined with cisplatin can enhance the inhibitory activity on the growth of melanoma
HTML PDF Collect
Share

Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in -mutant uveal melanoma

Frontiers of Medicine   Pages 784-798 doi: 10.1007/s11684-021-0911-0

Abstract: More than 85% of patients with uveal melanoma (UM) carry a GNAQ or GNA11αq/11 signaling for cell survival and proliferation than other melanoma

Keywords： uveal melanoma     mutant GNAQ/11     palmitoylation     BCL2     combination target therapy    

HTML PDF Collect
Share

Bacteria-mediated tumor-targeted delivery of tumstatin (54-132) significantly suppresses tumor growth in mouse model by inhibiting angiogenesis and promoting apoptosis

Frontiers of Medicine   Pages 873-882 doi: 10.1007/s11684-022-0925-2

Abstract: with VNP-Tum5 effectively suppressed tumor growth and prolonged survival in the mouse model of B16F10 melanomastudy is the first to use tumstatin-transformed VNP20009 as a tumor-targeted system for treatment of melanoma

Keywords： Salmonella VNP20009     tumstatin     B16F10     melanoma     apoptosis     angiogenesis    

HTML PDF Collect
Share

Neutron capture therapy clinical development in the world

Zhang Zichu,Jin Congjun,Liu Kai,Zhang Guozhen,Yang Lijun

Strategic Study of Chinese Academy of Engineering 2012, Volume 14, Issue 8,   Pages 100-105

Abstract: The BNCT clinical treatment situation and evaluation in glioblastoma (GBM), malignant melanoma, recurrent

Keywords： BNCT     GBM     malignant melanoma     recurent head & neck cancer     metastatic liver cancer    

HTML PDF Collect
Share

Title Author Date Type Operation

NETO2 promotes melanoma progression via activation of the Ca/CaMKII signaling pathway

Journal Article

Celecoxib in combination with retinoid CD437 inhibits melanoma A375 cell

Jianwen REN, Zhenhui PENG, Birong GUO, Min PAN

Journal Article

Inhibitory activity of Bifidobacterium adolescent combined with cisplatin on melanoma in mice and its

HUANG Hongying, LIU Guangchao, QI Yijun, DU Yaowu, CHEN Jugao, MA Yuanfang

Journal Article

Palmitoylation of GNAQ/11 is critical for tumor cell proliferation and survival in -mutant uveal melanoma

Journal Article

Bacteria-mediated tumor-targeted delivery of tumstatin (54-132) significantly suppresses tumor growth in mouse model by inhibiting angiogenesis and promoting apoptosis

Journal Article

Neutron capture therapy clinical development in the world

Zhang Zichu,Jin Congjun,Liu Kai,Zhang Guozhen,Yang Lijun

Journal Article